These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8388009)

  • 1. Increased interleukin-4 production by atopic mononuclear leukocytes correlates with increased cyclic adenosine monophosphate-phosphodiesterase activity and is reversible by phosphodiesterase inhibition.
    Chan SC; Li SH; Hanifin JM
    J Invest Dermatol; 1993 May; 100(5):681-4. PubMed ID: 8388009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes.
    Chan SC; Hanifin JM
    J Lab Clin Med; 1993 Jan; 121(1):44-51. PubMed ID: 8381148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-mycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis.
    Kanda N; Enomoto U; Watanabe S
    J Invest Dermatol; 2001 Dec; 117(6):1635-46. PubMed ID: 11886533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular 3',5'-adenosine cyclic monophosphate level regulates house dust mite-induced interleukin-13 production by T cells from mite-sensitive patients with atopic dermatitis.
    Kanda N; Watanabe S
    J Invest Dermatol; 2001 Jan; 116(1):3-11. PubMed ID: 11168792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphodiesterase inhibition by Ro 20-1724 reduces hyper-IgE synthesis by atopic dermatitis cells in vitro.
    Cooper KD; Kang K; Chan SC; Hanifin JM
    J Invest Dermatol; 1985 Jun; 84(6):477-82. PubMed ID: 3998494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiesterase inhibitors suppress proliferation of peripheral blood mononuclear cells and interleukin-4 and -5 secretion by human T-helper type 2 cells.
    Crocker IC; Townley RG; Khan MM
    Immunopharmacology; 1996 Mar; 31(2-3):223-35. PubMed ID: 8861748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monocyte phosphodiesterase abnormalities and dysregulation of lymphocyte function in atopic dermatitis.
    Hanifin JM; Chan SC
    J Invest Dermatol; 1995 Jul; 105(1 Suppl):84S-88S. PubMed ID: 7616004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of cyclic AMP in the effects of phosphodiesterase IV inhibitors on arachidonate release from mononuclear cells.
    Hichami A; Boichot E; Germain N; Legrand A; Moodley I; Lagente V
    Eur J Pharmacol; 1995 Oct; 291(2):91-7. PubMed ID: 8566180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type 4 phosphodiesterase inhibitors have clinical and in vitro anti-inflammatory effects in atopic dermatitis.
    Hanifin JM; Chan SC; Cheng JB; Tofte SJ; Henderson WR; Kirby DS; Weiner ES
    J Invest Dermatol; 1996 Jul; 107(1):51-6. PubMed ID: 8752839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocyte and monocyte localization of altered adrenergic receptors, cAMP responses, and cAMP phosphodiesterase in atopic dermatitis. A possible mechanism for abnormal radiosensitive helper T cells in atopic dermatitis.
    Cooper KD; Chan SC; Hanifin JM
    Acta Derm Venereol Suppl (Stockh); 1985; 114():41-7. PubMed ID: 2988252
    [No Abstract]   [Full Text] [Related]  

  • 11. Differential modulation of cytokine production by drugs: implications for therapy in heart failure.
    Matsumori A; Ono K; Sato Y; Shioi T; Nose Y; Sasayama S
    J Mol Cell Cardiol; 1996 Dec; 28(12):2491-9. PubMed ID: 9004165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective type IV phosphodiesterase inhibitors prevent IL-4-induced IgE production by human peripheral blood mononuclear cells.
    Coqueret O; Boichot E; Lagente V
    Clin Exp Allergy; 1997 Jul; 27(7):816-23. PubMed ID: 9249275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel phosphodiesterase inhibitor, T-440: possible management of eosinophilic inflammation by down-regulation of interleukin-5 production.
    Kaminuma O; Mori A; Suko M; Nishizaki Y; Kikkawa H; Ikezawa K; Okudaira H
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():16-8. PubMed ID: 8906105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterases in the rat renal vasculature.
    Jackson EK; Mi Z; Carcillo JA; Gillespie DG; Dubey RK
    J Cardiovasc Pharmacol; 1997 Dec; 30(6):798-801. PubMed ID: 9436820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of isoproterenol-induced cyclic AMP accumulation in LRM55 glial cells by phosphodiesterase.
    Madelian V; Shain W
    J Pharmacol Exp Ther; 1987 Nov; 243(2):618-23. PubMed ID: 2445955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. IV. An evaluation of a role for cyclic adenosine monophosphate.
    Cubeddu L; Barnes E; Weiner N
    J Pharmacol Exp Ther; 1975 Apr; 193(1):105-27. PubMed ID: 166157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-5 production by peripheral blood mononuclear cells of asthmatic patients is suppressed by T-440: relation to phosphodiesterase inhibition.
    Kaminuma O; Mori A; Suko M; Kikkawa H; Ikezawa K; Okudaira H
    J Pharmacol Exp Ther; 1996 Oct; 279(1):240-6. PubMed ID: 8858999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. gamma-interferon production in atopic dermatitis shows differential modification by phosphodiesterase and prostaglandin inhibition.
    Ostlere LS; Mallett RB; Kaminski A; Kaminski ER; Pereira RS; Holden CA
    Br J Dermatol; 1995 Jul; 133(1):1-5. PubMed ID: 7669618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antimycotics suppress interleukin-4 and interleukin-5 production in anti-CD3 plus anti-CD28-stimulated T cells from patients with atopic dermatitis].
    Kanda N
    Nihon Ishinkin Gakkai Zasshi; 2004; 45(3):137-42. PubMed ID: 15284827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective effects of phosphodiesterase inhibitors on different phosphodiesterases, adenosine 3',5'-monophosphate metabolism, and lipolysis in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1984 Oct; 115(4):1262-8. PubMed ID: 6207009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.